Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is EVEROLIMUS USP, with a corresponding US DMF Number 39412.
Remarkably, this DMF maintains an Active status since its submission on March 26, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 29, 2025, and payment made on September 19, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II